Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Pharmacyclics, Inc.
(NQ:
PCYC
)
81.86
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
84.42
Bid (Size)
70.31 (200)
Ask (Size)
82.05 (200)
Prev. Close
81.86
Today's Range
81.06 - 85.88
52wk Range
28.77 - 95.85
Shares Outstanding
72,783,040
Dividend Yield
N/A
Top News
More News
Pharmacyclics Earnings Review: 19 Days after Announcement Shares Up 11.3% (PCYC)
May 20, 2013
from
Comtex SmarTrend® News Briefs
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of...
Read More
category
NYSE:JNJ
,
NYSE:MRK
,
NASDAQ:PCYC
, and 2 more.
from
Forbes Real Time
More News
Read More
Benzinga's Top Upgrades
May 13, 2013
category
ORBK
,
DLR
,
Benzinga
, and 5 more.
from
Latest Articles from Benzinga.com
RBC Capital Upgrades Pharmacyclics (PCYC) to Outperform
May 13, 2013
from
StreetInsider.com News Articles
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Six Superstars for Your Biotech Portfolio: John McCamant
May 10, 2013
category
Pharmaceuticals
from
Trefis
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
category
AZN
,
JNJ
,
ALKS
, and 8 more.
from
Bio-Wire.Com
Bull’s Eye Report: Amgen (AMGN)
May 09, 2013
category
NASDAQ:PCYC
,
NYSE:CVD
,
NASDAQ:AMGN
from
InvestorPlace - Latest Headlines
Bull’s Eye Report: Pharmacyclics (PCYC)
May 07, 2013
category
NASDAQ:PCYC
,
NASDAQ:MDVN
,
NYSEARCA:XBI
, and 2 more.
from
InvestorPlace - Latest Headlines
Goldman Sachs Starts Pharmacyclics (PCYC) at Neutral
May 07, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.